Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Block for Dysphagia in Bulbar Palsy After Ischemic Stroke
NCT06225076Withdrawn
- Start
- Jan 2024
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of lidocaine in dysphagia and bulbar palsy (PBP) (2 arms). Primary endpoint: Penetration-Aspiration Scale at Day 20. Planned start Jan 2024; status: withdrawn.
02
Drugs
lidocaine
03
Conditions
dysphagiabulbar palsy (PBP)
Beyond the preview
Go deeper on NCT06225076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06225076.